Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Giovanni Di Perri"'
Autor:
C. Costa, Andrea Calcagno, Giovanni Di Perri, Ambra Barco, Ilaria Motta, Miriam Antonucci, Giovanni Rossi, Alice Trentalange, Pavilio Piccioni, Enrica Borgogno, Amedeo De Nicolò, Stefano Bonora, Veronica Pirriatore, Antonio D'Avolio
Publikováno v:
International journal of antimicrobial agents. 57(3)
Background The treatment of drug-sensitive tuberculosis (TB) is highly effective; however, many patients have suboptimal drug exposure, which possibly explains treatment failures and selection of resistance. This study aimed to describe the prevalenc
Autor:
Giovanni Di Perri, Jessica Cusato, Amedeo De Nicolò, Antonio D'Avolio, Lucio Boglione, Giuseppe Cariti, Gabriele Bonifacio
Publikováno v:
International journal of antimicrobial agents. 48(3)
The role of therapeutic drug monitoring (TDM) of entecavir (ETV) in the treatment of patients affected by chronic hepatitis B (CHB) has not yet been defined. Here we present an interim analysis regarding the role of ETV TDM in a prospective cohort of
Autor:
Rosario Urbino, Marco Ranieri, Antonio D'Avolio, Silvia Corcione, Vito Fanelli, Giovanni Di Perri, Sarah Allegra, Francesco Giuseppe De Rosa
Publikováno v:
International Journal of Antimicrobial Agents. 49:784-785
Autor:
Sarah Allegra, Jessica Cusato, Andrea Calcagno, Antonio D'Avolio, Stefano Bonora, L. Marinaro, Anna Leggieri, Giovanni Di Perri, Marco Simiele, Cristina Tomasello
Publikováno v:
International journal of antimicrobial agents. 47(2)
The pharmacogenetics and pharmacokinetics of efavirenz (EFV) have been widely studied, although data in the Italian population are limited. Single nucleotide polymorphisms (SNPs) in the CYP2B6 gene have been associated with increased EFV plasma conce